We are live on !
Find out more
Stanley-Laman Group Portfolio holdings
AUM
$915M
Turnover
11.67%
1-Year Est. Return
50.26%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+50.26%
3 Year Est. Return
+113.93%
5 Year Est. Return
+106.15%
10 Year Est. Return
+368.2%
AUM
$915M
AUM Growth
-$69.1M
(-7%)
Cap. Flow
-$11.3M
Cap. Flow % of AUM
Cap. Flow %
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
19.78%
Holding
317
New
19
Increased
50
Reduced
138
Closed
18
Avg Time Held
2.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$6.86M |
| 2 |
Glacier Bancorp
GBCI
|
+$5.86M |
| 3 |
MNTN Inc
MNTN
|
+$4.47M |
| 4 |
The Mosaic Company
MOS
|
+$4.43M |
| 5 |
Fifth Third Bancorp
FITB
|
+$2.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantheus
LNTH
|
+$7.54M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$4.82M |
| 3 |
Zeta Global
ZETA
|
+$4.57M |
| 4 |
Hartford Financial Services
HIG
|
+$4.52M |
| 5 |
GXO Logistics
GXO
|
+$4.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.13% |
| 2 | Miscellaneous | 15.81% |
| 3 | Industrials | 11.61% |
| 4 | Energy | 8.7% |
| 5 | Healthcare | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Union Pacific
UNP
$180B
| $3.8M | 0.42% |
13,971
-221
| -2% | -$64.3K |
2020 Q1
26 quarters
|
|
77
Neurocrine Biosciences
NBIX
$16.9B
| $3.8M | 0.42% |
26,792
-654
| -2% | -$105K |
2024 Q2
9 quarters
|
|
78
Regal Rexnord
RRX
$11.7B
| $3.75M | 0.41% |
24,199
+7,114
| +42% | +$1.28M |
2026 Q2
1 quarter
|
|
79
TJX Companies
TJX
$148B
| $3.73M | 0.41% |
28,205
-469
| -2% | -$67.6K |
2019 Q1
30 quarters
|
|
80
Belden
BDC
$3.98B
| $3.73M | 0.41% |
34,574
-895
| -3% | -$104K |
2026 Q2
1 quarter
|
|
81
AstraZeneca
AZN
$286B
| $3.73M | 0.41% |
23,076
-517
| -2% | -$86.2K |
2023 Q3
12 quarters
|
|
82
Lockheed Martin
LMT
$138B
| $3.65M | 0.4% |
7,159
-125
| -2% | -$68.7K |
2018 Q1
34 quarters
|
|
83
Diamondback Energy
FANG
$51.6B
| $3.64M | 0.4% |
19,823
-324
| -2% | -$63.4K |
2022 Q2
17 quarters
|
|
84
Fluor
FLR
$6.28B
| $3.58M | 0.39% |
74,759
-1,658
| -2% | -$86.4K |
2021 Q4
19 quarters
|
|
85
OSI Systems
OSIS
$3.03B
| $3.57M | 0.39% |
18,382
-340
| -2% | -$72.4K |
2024 Q1
10 quarters
|
|
86
Petrobras Class A
PBR.A
$103B
| $3.56M | 0.39% |
170,408
-3,549
| -2% | -$60.6K |
2026 Q1
2 quarters
|
|
87
L3Harris
LHX
$50.7B
| $3.49M | 0.38% |
14,759
-242
| -2% | -$65.9K |
2022 Q1
18 quarters
|
|
88
Stifel
SF
$10.9B
| $3.45M | 0.38% |
49,284
-867
| -2% | -$68.4K |
2023 Q3
12 quarters
|
|
89
Axsome Therapeutics
AXSM
$7.45B
| $3.45M | 0.38% |
18,695
-475
| -2% | -$103K |
2025 Q3
4 quarters
|
|
90
Automatic Data Processing
ADP
$122B
| $3.4M | 0.37% |
13,194
-221
| -2% | -$58.6K |
2020 Q3
24 quarters
|
|
91
Energy Fuels
UUUU
$1.75B
| $3.37M | 0.37% |
305,883
-7,641
| -2% | -$100K |
2024 Q1
10 quarters
|
|
92
Reliance Global Group
XGPU
$3.11M
| $3.37M | 0.37% |
8,766
+11
| +0.1% | +$28 |
2025 Q3
4 quarters
|
|
93
United Parcel Service
UPS
$95.7B
| $3.37M | 0.37% |
36,016
-632
| -2% | -$66.4K |
2020 Q4
23 quarters
|
|
94
Target
TGT
$73.3B
| $3.34M | 0.36% |
21,297
-363
| -2% | -$54.6K |
2021 Q1
22 quarters
|
|
95
Air Products & Chemicals
APD
$70.5B
| $3.32M | 0.36% |
11,930
-264
| -2% | -$78.5K |
2026 Q2
1 quarter
|
|
96
Ivanhoe Electric
IE
$1.08B
| $3.26M | 0.36% |
328,657
+82,758
| +34% | +$825K |
2026 Q2
1 quarter
|
|
97
Palo Alto Networks
PANW
$264B
| $3.25M | 0.36% |
8,184
-221
| -3% | -$78.6K |
2025 Q3
4 quarters
|
|
98
LyondellBasell Industries
LYB
$20.8B
| $3.23M | 0.35% |
56,194
-875
| -2% | -$53.6K |
2016 Q3
40 quarters
|
|
99
Albemarle
ALB
$11B
| $3.18M | 0.35% |
30,028
-682
| -2% | -$84.6K |
2025 Q3
4 quarters
|
|
100
Select Water Solutions
WTTR
$2.24B
| $3.13M | 0.34% |
158,237
-68,088
| -30% | -$1.35M |
2023 Q3
12 quarters
|
|
Similar funds
WCM
SA
Stanley-Laman Group's Q3 2026 Portfolio in Review
As of Q3 2026, Stanley-Laman Group held 317 positions worth $915M, down 7% from $984M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Stanley-Laman Group's Q3 2026 filing shows 19 new, 50 increased, 138 reduced and 18 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 12,984 shares worth $6.54M. The largest sale was Lantheus, an estimated $7.54M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Miscellaneous and Industrials.
- Stanley-Laman Group's largest Q3 2026 buy was Madrigal Pharmaceuticals: 12,984 shares worth $6.54M.
- Stanley-Laman Group added most to Marten Transport in Q3 2026, an estimated $1.82M increase.
- Stanley-Laman Group's biggest Q3 2026 reduction was AAR Corp, cutting an estimated $2.12M.
- Stanley-Laman Group fully exited Lantheus in Q3 2026, selling an estimated $7.54M.
- Stanley-Laman Group's ten largest holdings make up 20% of its $915M portfolio in Q3 2026.
- Stanley-Laman Group opened 19 new positions and closed 18 in Q3 2026.
- Stanley-Laman Group's portfolio value fell 7% quarter-over-quarter to $915M.
Based on Stanley-Laman Group's 13F filing for Q3 2026, filed 20 Oct 2026.